全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

糖尿病周围神经病变治疗研究进展
Advances in the Treatment of Diabetic Peripheral Neuropathy

DOI: 10.12677/ACM.2023.1361262, PP. 9013-9022

Keywords: 糖尿病,周围神经病变,发病机制,临床治疗,研究进展
Diabetes Mellitus
, Peripheral Neuropathy, Pathogenesis, Clinical Treatment, Research Progress

Full-Text   Cite this paper   Add to My Lib

Abstract:

糖尿病周围神经病变是临床上常见的一种危害严重的慢性并发症,其致残率极高,不仅对患者的生命安全以及心理健康等造成巨大的伤害,还会加重患者家庭乃至社会民生的负担。因此,临床上需要加强对糖尿病周围神经病变的发病机制以及临床治疗的相关研究,不断提高临床治疗效果,以保证患者临床治疗的有效性和安全性,促进其机体功能的改善,从而帮助患者早日康复。
Diabetic peripheral neuropathy is a common chronic complication with serious clinical hazards and a very high disability rate, which not only causes great harm to patients’ life safety and psychologi-cal health, but also increases the burden of patients’ families and even society’s livelihood. There-fore, clinical research on the pathogenesis and clinical treatment of diabetic peripheral neuropathy needs to be strengthened to continuously improve the clinical treatment effect to ensure the effec-tiveness and safety of clinical treatment for patients and to promote the improvement of their body functions, so as to help patients recover as soon as possible.

References

[1]  Feldman, E.L., Callaghan, B.C., Pop-Busui, R., et al. (2019) Diabetic Neuropathy. Nature Reviews Disease Primers, 5, Article No. 42.
https://doi.org/10.1038/s41572-019-0092-1
[2]  Selvarajah, D., Kar, D., Khunti, K., Davies, M.J., Scott, A.R., Walker, J. and Tesfaye, S. (2019) Diabetic Peripheral Neuropathy: Advances in Diagnosis and Strategies for Screening and Early Intervention. The Lancet Diabetes & Endocrinology, 7, 938-948.
https://doi.org/10.1016/S2213-8587(19)30081-6
[3]  Zakin, E., Abrams, R. and Simpson, D.M. (2019) Diabetic Neuropathy. Seminars in Neurology, 39, 560-569.
https://doi.org/10.1055/s-0039-1688978
[4]  Yang, H., Sloan, G., Ye, Y., Wang, S., Duan, B., Tesfaye, S. and Gao, L. (2019) New Perspective in Diabetic Neuropathy: From the Periphery to the Brain, a Call for Early Detection and Precision Medicine. Frontiers in Endocrinology, 10, Article 929.
https://doi.org/10.3389/fendo.2019.00929
[5]  Ling, E., Lepow, B., Zhou, H., Enriquez, A., Mullen, A. and Najafi, B. (2020) The Impact of Diabetic Foot Ulcers and Unilateral Offloading Footwear on Gait in People with Diabetes. Clin-ical Biomechanics, 73, 157-161.
https://doi.org/10.1016/j.clinbiomech.2020.01.014
[6]  Jeyam, A., Mcgurnaghan, S.J., Blackbourn, L.A.K., et al. (2020) Diabetic Neuropathy Is a Substantial Burden in People with Type 1 Diabetes and Is Strongly Associated with So-cioeconomic Disadvantage: A Population-Representative Study from Scotland. Diabetes Care, 43, 734-742.
https://doi.org/10.2337/dc19-1582
[7]  Davidson, K.W., Barry, M.J., Mangione, C.M., et al. (2021) Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement. JAMA, 326, 736-743.
https://doi.org/10.1001/jama.2021.12531
[8]  Li, C., Kim, H.J., Back, S.K. and Na, H.S. (2021) Common and Discrete Mechanisms Underlying Chronic Pain and Itch: Peripheral and Central Sensitization. Pflügers Archiv-European Journal of Physiology, 473, 1603-1615.
https://doi.org/10.1007/s00424-021-02599-y
[9]  Bennett, D.L., Clark, A.J., Huang, J., et al. (2019) The Role of Voltage-Gated Sodium Channels in Pain Signaling. Physiological Reviews, 99, 1079-1151.
https://doi.org/10.1152/physrev.00052.2017
[10]  Wang, M. and Thyagarajan, B. (2022) Pain Pathways and Poten-tial New Targets for Pain Relief. Biotechnology and Applied Biochemistry, 69, 110-123.
https://doi.org/10.1002/bab.2086
[11]  Zamponi, G.W., Lewis, R.J., Todorovic, S.M., Arneric, S.P. and Snutch, T.P. (2009) Role of Voltage-Gated Calcium Channels in Ascending Pain Pathways. Brain Research Reviews, 60, 84-89.
https://doi.org/10.1016/j.brainresrev.2008.12.021
[12]  Matsushita, Y., Manabe, M., Kitagawa, I., Higuchi, M., Hosaka, Y.Z. and Kitamura, N. (2021) Inhibition of Transient Receptor Potential Vanilloid Type 1 through α2 Adrenergic Receptors at Peripheral Nerve Terminals Relieves Pain. Journal of Veterinary Medical Science, 83, 1570-1581.
https://doi.org/10.1292/jvms.21-0429
[13]  Li, J., Zhan, L., Xu, C., et al. (2020) Prolonged Use of NMDAR An-tagonist Develops Analgesic Tolerance in Neuropathic Pain via Nitric Oxide Reduction-Induced GABAergic Disinhibi-tion. Neurotherapeutics, 17, 1016-1030.
https://doi.org/10.1007/s13311-020-00883-w
[14]  Beggs, S., Trang, T. and Salter, M.W. (2012) P2X4R+ Micro-glia Drive Neuropathic Pain. Nature Neuroscience, 15, 1068-1073.
https://doi.org/10.1038/nn.3155
[15]  Masuda, T., Ozono, Y., Mikuriya, S., et al. (2016) Dorsal Horn Neurons Release Extracellular ATP in a VNUT- Dependent Manner that Underlies Neuropathic Pain. Nature Communications, 7, Article No. 12529.
https://doi.org/10.1038/ncomms12529
[16]  Zenker, J., Ziegler, D. and Chrast, R. (2013) Novel Pathogenic Path-ways in Diabetic Neuropathy. Trendsin Neurosciences, 36, 439-449.
https://doi.org/10.1016/j.tins.2013.04.008
[17]  Baum, P., Toyka, K.V., Blüher, M., Kosacka, J. and Nowicki, M. (2021) Inflammatory Mechanisms in the Pathophysiology of Diabetic Peripheral Neuropathy (DN)—New Aspects. In-ternational Journal of Molecular Sciences, 22, Article 10835.
https://doi.org/10.3390/ijms221910835
[18]  Xue, T., Zhang, X., Xing, Y., et al. (2021) Advances about Immunoinflammatory Pathogenesis and Treatment in Diabetic Periph-eral Neuropathy. Frontiers in Pharmacology, 12, Article 748193.
https://doi.org/10.3389/fphar.2021.748193
[19]  Jia, W., Weng, J., Zhu, D., et al. (2019) Standards of Medical Care for Type 2 Diabetes in China 2019. Diabetes/ Metabolism Research and Reviews, 35, e3158.
https://doi.org/10.1002/dmrr.3158
[20]  Waldfogel, J.M., Nesbit, S.A., Dy, S.M., et al. (2017) Pharmacotherapy for Diabetic Peripheral Neuropathy Pain and Quality of Life: A Systematic Review. Neurology, 88, 1958-1967.
https://doi.org/10.1212/WNL.0000000000003882
[21]  Schneider, C., Breilmann, J., Reuter, B., Becker, T. and K?sters, M. (2021) Systematic Evaluation of the ‘Efficacy-Effectiveness Gap’ in the Treatment of Depression with Ven-lafaxine and Duloxetine. Acta Psychiatrica Scandinavica, 144, 113-124.
https://doi.org/10.1111/acps.13293
[22]  Spallone, V. (2012) Management of Painful Diabetic Neuropathy: Guide-line Guidance or Jungle? Current Diabetes Reports, 12, 403-413.
https://doi.org/10.1007/s11892-012-0287-2
[23]  Guan, Y., Ding, X., Cheng, Y., et al. (2011) Efficacy of Pregaba-lin for Peripheral Neuropathic Pain: Results of an 8- Week, Flexible-Dose, Double-Blind, Placebo-Controlled Study Conducted in China. Clinical Therapeutics, 33, 159- 166.
https://doi.org/10.1016/j.clinthera.2011.02.007
[24]  Chong, M.S. and Heste, J. (2007) Diabetic Painful Neuropathy: Current and Future Treatment Options. Drugs, 67, 569-585.
https://doi.org/10.2165/00003495-200767040-00006
[25]  Harati, Y., Gooch, C., Swenson, M., et al. (1998) Dou-ble-Blind Randomized Trial of Tramadol for the Treatment of the Pain of Diabetic Neuropathy. Neurology, 50, 1842-1826.
https://doi.org/10.1212/WNL.50.6.1842
[26]  Tesfaye, S., Vileikyte, L., Rayman, G., et al. (2011) Painful Diabetic Peripheral Neuropathy: Consensus Recommendations on Diagnosis, Assessment and Management. Di-abetes/Metabolism Research and Reviews, 27, 629-638.
https://doi.org/10.1002/dmrr.1225
[27]  Pafili, K. and Papanas, N. (2021) Considerations for Single- versus Multi-ple-Drug Pharmacotherapy in the Management of Painful Diabetic Neuropathy. Expert Opinion on Pharmacotherapy, 22, 2267-2280.
https://doi.org/10.1080/14656566.2021.1909570
[28]  Mijnhout, G.S., Alkhalaf, A., Kleefstra, N., et al. (2010) Alpha Lipoic Acid: A NEW treatment for Neuropathic Pain in Patients with Diabetes? The Netherlands Journal of Medi-cine, 68, 158-162.
[29]  Hussain, N., Said, A.S.A., Javaid, F.A., et al. (2021) The Efficacy and Safety Profile of Capsai-cin 8% Patch versus 5% Lidocaine patch in Patients with Diabetic Peripheral Neuropathic Pain: A Randomized, Place-bo-Controlled Study of South Asian Male Patients. Journal of Diabetes & Metabolic Disorders, 20, 271-278.
https://doi.org/10.1007/s40200-021-00741-2
[30]  Li, M., Su, H., Xiang, Y., et al. (2013) Features Analysis on Traditional Chinese Medicine Syndromes in Patients with Diabetic Peripheral Neuropathy. Journal of Traditional Chi-nese Medicine, 33, 637-641.
https://doi.org/10.1016/S0254-6272(14)60034-0
[31]  Xu, J.Y. and Gao, H.Y. (2018) Combined Treatment of Tra-ditional Chinese Medicine and Western Medicine in the Treatment of Diabetic Peripheral Neuropathy. Journal of Biolog-ical Regulators and Homeostatic Agents, 32, 945-949.
[32]  Cao, W., Wang, Q., Rong, Y.U., Su, L., Wu, M. and Liu, X. (2017) Analysis of Traditional Chinese Medicine Treatment of Diabetic Peripheral Neuropathy Based on Literature Re-search. Liaoning Journal of Traditional Chinese Medicine, 44, 1121-11123.
[33]  Yu, J., Zhang, Y., Sun, S., et al. (2006) Inhibitory Effects of Astragaloside IV on Diabetic Peripheral Neuropathy in Rats. Canadian Journal of Physiology and Pharmacology, 84, 579-587.
https://doi.org/10.1139/y06-015
[34]  Xue, B., Wang, L., Zhang, Z., Wang, R., Xia, X., Han, P., Cao, L., Liu, Y. and Sun, L. (2017) Puerarin May Protect against Schwann Cell Damage Induced by Glu-cose Fluctuation. Journal of Natural Medicines, 71, 472-481.
https://doi.org/10.1007/s11418-016-1067-0
[35]  Taliyan, R. and Sharma P.L. (2012) Protective Effect and Potential Mechanism of Ginkgo biloba Extract EGb 761 on STZ-Induced Neuropathic Pain in Rats. Phytotherapy Research, 26, 1823-1829.
https://doi.org/10.1002/ptr.4648
[36]  Yang, X., Yao, W., Shi, H., Liu, H., Li, Y., Gao, Y., Liu, R. and Xu, L. (2016) Paeoniflorin Protects Schwann Cells against High Glucose Induced Oxidative Injury by Activating Nrf2/ARE Pathway and Inhibiting Apoptosis. Journal of Ethnopharmacology, 185, 361-369.
https://doi.org/10.1016/j.jep.2016.03.031
[37]  Liu, N., Li, Y.X., Gong, S.S., et al. (2016) Antinociceptive Effects of Gentiopicroside on Neuropathic Pain Induced by Chronic Constriction Injury in Mice: A Behavioral and Electrophysi-ological Study. Canadian Journal of Physiology and Pharmacology, 94, 769-778.
https://doi.org/10.1139/cjpp-2015-0462
[38]  Zhang, Q., Song, W., Zhao, B., Xie, J., Sun, Q., Shi, X., Yan, B., Tian, G. and Liang, X. (2021) Quercetin Attenuates Diabetic Peripheral Neuropathy by Correcting Mitochondrial Ab-normality via Activation of AMPK/PGC-1α Pathway in Vivo and in Vitro. Frontiers in Neuroscience, 15, Article 636172.
https://doi.org/10.3389/fnins.2021.636172
[39]  Zhang, Y., Gong, G., Zhang, X., et al. (2019) Huangqi Guizhi Wuwu Decoction for Diabetic Peripheral Neuropathy: Protocol for a Systematic Review. Medicine, 98, e16696.
https://doi.org/10.1097/MD.0000000000016696
[40]  Lee, H.S., Lee, I.H., Kang, K., et al. (2020) An Investigation of the Molecular Mechanisms Underlying the Analgesic Effect of Jakyak-Gamcho Decoction: A Network Pharmacology Study. Evidence-Based Complementary and Alternative Medicine, 2020, Article ID: 6628641.
https://doi.org/10.1155/2020/6628641
[41]  Pang, B. and Ni, Q. (2019) [Application of Classical Formula in Treat-ment of Diabetes]. China Journal of Chinese Materia Medica, 44, 3895-3898. (In Chinese)
[42]  Ding, R., Wang, Y., Zhu, J.P., et al. (2020) Danggui Sini Decoction Protects against Oxaliplatin-Induced Peripheral Neuropathy in Rats. Journal of Integrative Neuroscience, 19, 663-671.
https://doi.org/10.31083/j.jin.2020.04.1154
[43]  Zheng, W., Wang, G., Zhang, Z., Wang, Z. and Ma, K. (2020) Research Progress on Classical Traditional Chinese Medicine Formula Liuwei Dihuang Pills in the Treatment of Type 2 Diabetes. Biomedicine & Pharmacotherapy, 121, Article ID: 109564.
https://doi.org/10.1016/j.biopha.2019.109564
[44]  Zhang, Y., Jin, D., Duan, Y., et al. (2021) Efficacy of Mudan Granule (Combined With Methylcobalamin) on Type 2 Diabetic Peripheral Neuropathy: Study Protocol for a Dou-ble-Blind, Randomized, Placebo-Controlled, Parallel-Arm, Multi-Center Trial. Frontiers in Pharmacology, 12, Article 676503.
https://doi.org/10.3389/fphar.2021.676503
[45]  An, X., Jin, D., Duan, L., Zhao, S., Zhou, R., Lian, F. and Tong, X. (2020) Direct and Indirect Therapeutic Effect of Traditional Chinese Medicine as an Add-On for Non-Proliferative Diabetic Retinopathy: A Systematic Review and Meta-Analysis. Chinese Medicine, 15, Article No. 99.
https://doi.org/10.1186/s13020-020-00380-4
[46]  Li, T., Li, H., Wu, Y., et al. (2021) Efficacy and Safety of Shenqi Jiangtang Granules Plus Oral Hypoglycemic Agent in Patients with Type 2 Diabetes Mellitus: A Protocol for Systematic Review and Meta-Analysis of 15 RCTs. Medicine, 100, e23578.
https://doi.org/10.1097/MD.0000000000023578
[47]  Ye, C. (2017) To Observe the Curative Effect of Xiaoshuan Enteric Capsule Combined with Mecobalamin on Diabetic Peripheral Neuropathy. China Continuing Medical Education, 9, 121-123.
[48]  Guo, J., Meng, Q.H., Yin, Q.Y., et al. (2014) [Study of Effect of Tongsaimai Tablets on Experimental Diabetic Foot Model Rats]. China Journal of Chinese Materia Medica, 39, 2091-2096. (In Chinese)
[49]  Kang, S., Zhong, Y., Liu, D. and Li, W. (2021) Traditional Chinese Medicine Fumigation as Auxiliary Treatment of Diabetic Pe-ripheral Neuropathy: A Protocol for Systematic Review and Meta-Analysis. Medicine, 100, e24200.
https://doi.org/10.1097/MD.0000000000024200
[50]  Wang, X., Li, Q., Han, X., et al. (2021) Electroacupuncture Alleviates Diabetic Peripheral Neuropathy by Regulating Glycolipid-Related GLO/AGEs/RAGE Axis. Frontiers in En-docrinology, 12, Article 655591.
https://doi.org/10.3389/fendo.2021.655591
[51]  Li, J., Hu, X., Liang, F., et al. (2019) Therapeutic Effects of Mox-ibustion Simultaneously Targeting Nrf2 and NF-κB in Diabetic Peripheral Neuropathy. Applied Biochemistry and Bio-technology, 189, 1167-1182.
https://doi.org/10.1007/s12010-019-03052-8
[52]  Fu, Q., Yang, H., Zhang, L., et al. (2020) Traditional Chinese Medicine Foot Bath Combined with Acupoint Massage for the Treatment of Diabetic Peripheral Neuropathy: A System-atic Review and Meta-Analysis of 31 RCTs. Diabetes/ Metabolism Research and Reviews, 36, e3218.
https://doi.org/10.1002/dmrr.3218
[53]  Wang, L.Q., Chen, Z., Zhang, K., et al. (2018) Zusanli (ST36) Acupoint Injection for Diabetic Peripheral Neuropathy: A Systematic Review of Randomized Controlled Trials. The Journal of Al-ternative and Complementary Medicine, 24, 1138-1149.
https://doi.org/10.1089/acm.2018.0053
[54]  Gandhi, K.R., Verma, V.K., Chavan, S.K., et al. (2013) The Morphology of Lumbar Sympathetic Trunk in Humans: A Cadaveric Study. Folia Morphologica, 72, 217-222.
https://doi.org/10.5603/FM.2013.0036
[55]  邓兆宏, 尚静, 唐杰. 腰交感神经阻滞有关解剖结构[J]. 解剖学杂志, 2012, 35(5): 642-644.
[56]  卢振和, 高崇荣, 张丽雯, 等. 射频热凝腰交感神经节的临床应用[J]. 中华麻醉学杂志, 2002, 22(12): 752-754.
[57]  Dominkus, M., Kepplinger, B., Baue, W., et al. (1991) Percutaneous Radiofrequency Thermolesion of the Sympathetic Chain in the Treatment of Peripheral Vascular Disease. Acta Medica Austriaca, 18, 69-70.
[58]  于敏, 薛天宇, 张鑫, 等. 糖尿病周围神经病变药物治疗研究进展[J]. 中国医师进修杂志, 2022, 45(5): 473-476.
[59]  薛婧. 糖尿病周围神经病变危险因素及治疗研究进展[J]. 中国城乡企业卫生, 2022, 37(8): 33-35.
[60]  Li, M., Yao, L., Huang, H., Zheng, H., Cao, J., Wang, G., Liu, Y. and Wang, H. (2021) Study on Acupuncture in the Treatment of Painful Diabetic Peripheral Neuropathy Based on rs-fMRI: A Protocol for Systematic Review and Meta-Analysis. BMJ Open, 11, 825-829.
https://doi.org/10.1136/bmjopen-2021-055874
[61]  Faraz, A., Ashraf, H., Singhal, S., Hussain, F. and Jaiswal, J. (2020) P47 Correlation of Neurophysiological Parameters with HRV in Patients of Diabetic Peripheral Neuropathy Across Sectional Study. Clinical Neurophysiology, 131, 1043- 1046.
https://doi.org/10.1016/j.clinph.2019.12.053

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133